Naoko Yoshizawa-Sugata

Naoko Yoshizawa-Sugata

Auto-generated profile, based on publicly available information

Naoko Yoshizawa-Sugata

Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
AFAlessandro Fracassi
Alessandro Fracassi
JCJianbo Cao
Jianbo Cao
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
ÉTÉva Tóth
Éva Tóth
CACorey Archer
Corey Archer
YYYoko Yamakoshi
Yoko Yamakoshi
Low-density lipoprotein (LDL)-mimetic lipid nanoparticles (LNPs), decorated with MRI contrast agents and fluorescent dyes, were prepared by the covalent attachment of apolipoprotein-mimetic peptide (P), Gd(III)-chelate (Gd), and sulforhodamine B (R) moieties on the LNP surface. The functionalized LNPs were prepared using the amide-forming potassium acyltrifluoroborate (KAT) ligation reaction. The KAT groups on the surface of LNPs were allowed to react with the corresponding hydroxylamine (HA) derivatives of P and Gd to provide bi-functionalized LNPs (PGd-LNP). The reaction proceeded with excellent yields, as observed by ICP-MS (for B and Gd amounts) and MALDI-TOF-MS data, and did not alter the morphology of the LNPs (mean diameter: ca. 50 nm), as shown by DLS and cryoTEM analyses. With the help of the efficient KAT ligation, a high payload of Gd(III)-chelate on the PGd-LNP surface (ca. 2800 Gd atoms per LNP) was successfully achieved and provided a high r1 relaxivity (r1 = 22.0 s−1 mM−1 at 1.4 T/60 MHz and 25 °C; r1 = 8.2 s−1 mM−1 at 9.4 T/400 MHz and 37 °C). This bi-functionalized PGd-LNP was administered to three atherosclerotic apoE−/− mice to reveal the clear enhancement of atherosclerotic plaques in the brachiocephalic artery (BA) by MRI, in good agreement with the high accumulation of Gd in the aortic arch as shown by ICP-MS. The parallel in vivo MRI and ex vivo studies of whole mouse cryo-imaging were performed using triply functionalized LNPs with P, Gd, and R (PGdR-LNP). The clear presence of atherosclerotic plaques in BA was observed by ex vivo bright field cryo-imaging, and they were also observed by high emission fluorescent imaging. These directly corresponded to the enhanced tissue in the in vivo MRI of the identical mouse.

21 August 2024 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
Tamas NemethTamas Nemeth
Tamas Nemeth
APAgnès Pallier
Agnès Pallier
ÇÇÇetin Çelik
Çetin Çelik
GZGarda Zoltán
Garda Zoltán
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
YYYoko Yamakoshi
Yoko Yamakoshi
Three water-soluble Mn(III)-porphyrin complexes with cationic pyridyl side groups bearing COOH- or OH-terminated carbon chains in the meta or para positions have been synthesized as probes for both magnetic resonance imaging (MRI) and photodynamic therapy (PDT). The complexes Mn-1, Mn-2, and Mn-3 are highly water-soluble, and their relaxivities range between 10 and 15 mM-1 s-1, at 20-80 MHz and 298 K, 2-3 times higher than that of commercial Gd(III)-based agents. The complexes containing carboxylate (Mn-2) or alcoholic (Mn-3) side chains in the para position are endowed with higher relaxivities and have also shown efficient photoinduced DNA cleavage and singlet oxygen (1O2) generation. Mn-3 with stronger photoinduced DNA cleavage has also revealed stabilizing and binding activities for G4 DNA, at a similar level as the known G4 binder Mn-TMPyP4. Nevertheless, the G4-binding activity of Mn-3 was nonspecific. Preliminary tests evidenced photocytotoxicity of Mn-3 on HeLa cells without a significant effect in the absence of light. Altogether, these results underline the potential of such water-soluble Mn(III)-porphyrins for the development of multimodal approaches combining MRI and PDT.

1 November 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
SYSatoshi Yamazaki
Satoshi Yamazaki
KMKaoru Mita-Yoshida
Kaoru Mita-Yoshida
TOTomio Ono
Tomio Ono
YNYasumasa Nishito
Yasumasa Nishito
HMHisao Masai
Hisao Masai
Rif1 regulates DNA replication timing and double-strand break repair, and its depletion induces transcriptional bursting of two-cell (2C) zygote-specific genes in mouse ES cells. However, how Rif1 regulates zygotic transcription is unclear. We show here that Rif1 depletion promotes the formation of a unique Zscan4 enhancer structure harboring both histone H3 lysine 27 acetylation (H3K27ac) and moderate levels of silencing chromatin mark H3K9me3. Curiously, another enhancer mark H3K4me1 is missing, whereas DNA methylation is still maintained in the structure, which spreads across gene bodies and neighboring regions within the Zscan4 gene cluster. We also found by function analyses of Rif1 domains in ES cells that ectopic expression of Rif1 lacking N-terminal domain results in upregulation of 2C transcripts. This appears to be caused by dominant negative inhibition of endogenous Rif1 protein localization at the nuclear periphery through formation of hetero-oligomers between the N-terminally truncated and endogenous forms. Strikingly, in murine 2C embryos, most of Rif1-derived polypeptides are expressed as truncated forms in soluble nuclear or cytosolic fraction and are likely nonfunctional. Toward the morula stage, the full-length form of Rif1 gradually increased. Our results suggest that the absence of the functional full-length Rif1 due to its instability or alternative splicing and potential inactivation of Rif1 through dominant inhibition by N-terminally truncated Rif1 polypeptides may be involved in 2C-specific transcription program.

12 May 2023 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
Tamas NemethTamas Nemeth
Tamas Nemeth
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
APAgnes Pallier
Agnes Pallier
YTYouichi Tajima
Youichi Tajima
YMYue Ma
Yue Ma
YYYoko Yamakoshi
Yoko Yamakoshi

1 October 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
ÇÇÇetin Çelik
Çetin Çelik
NKNaoko Kakusho
Naoko Kakusho
TXTianyu Xu
Tianyu Xu
SLSung Sik Lee
Sung Sik Lee
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
YYYoko Yamakoshi
Yoko Yamakoshi
Porphyrins are well-known photosensitizers (PSs), a few of which are clinically approved drugs for use in photodynamic therapy (PDT). Porphyrin derivatives including tetra-cationic porphyrins, e.g. TMPyP4, are also well-studied binders for G-quadruplex (G4) DNA. Since G4 DNAs are known to play a role in malignant transformation of cells, a variety of G4 binders have been used in cancer therapy by regulating the function of G4 DNA. In this study, two water-soluble porphyrins (1 and 2), with four terminal cationic moieties connected with alkyl linkers were synthesized as bifunctional molecules for simultaneous G4 binding and PDT-PS. Photoinduced singlet oxygen (1O2) generation and DNA cleavage were tested under visible light irradiation revealing the efficient generation of 1O2 in line with photoinduced DNA cleavages. Studies in a cancer cell line (HeLa) and a normal fibroblast (NHDF) cells revealed significantly stronger photocytotoxicities of these porphyrins (1 and 2) in comparison to TMPyP4, presumably due to better cellular internalization – as observed by flow cytometry. Interestingly, enhanced photocytotoxicity of 1 and 2 was observed in HeLa in comparison to NHDF. This may be related to the fact that more G4 DNAs are present in the nuclei of cancer cell lines to allow binding of porphyrins 1 and 2, as observed by fluorescence microscopy. The interactions of porphyrins 1 or 2 with a G4-forming telomeric DNA were evaluated by a FRET assay and spectroscopic methods (fluorescence, UV-vis, and CD) and showed selective binding to G4 DNA. The results show the potential of porphyrins 1 and 2 as PDT-PSs targeting cancer cells with higher G4-forming domains.

7 September 2022
Verified
Book Chapter
Closed access
PDF file
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
HMHisao Masai
Hisao Masai